Introduction
Cell growth and division have long been studied as two inherently separate processes to understand the fundamental mechanisms that drive these two systems. However, consistent evidence has pointed toward the coupling of growth and division, suggesting the existence of molecular ties that bind these two processes. The signaling pathways that converge to connect protein synthesis to regulation of the cell cycle have thus far remained largely elusive.
The Mdm2-p53 stress response pathway is an important regulator of cellular homeostasis. A variety of mitogenic and genotoxic stressors converge on this pathway to elicit a protective p53-dependent stress response resulting in cell cycle arrest, apoptosis, DNA repair or replicative senescence (Levine et al., 2006) . As the cellular 'gatekeeper', p53 remains at the pinnacle of cellular surveillance to regulate cell growth and proliferative homeostasis (Vogelstein et al., 2000) . Mdm2 is an E3 ubiquitin ligase that binds to p53 to promote ubiquitination and degradation of the protein.
As p53 is largely regulated at a posttranslational level, the primary mechanism for induced stability is modifications to Mdm2-p53 interactions. There is a large array of regulatory factors that act on Mdm2 to regulate p53 stability and function. One example is the INK4a/ ARF locus, which encodes the alternative reading frame (ARF) tumor suppressor; a small nucleolar protein.
In response to oncogenic stress such as RAS or c-myc overexpression, ARF binds to and inhibits Mdm2-mediated p53 ubiquitination and degradation (Sharpless, 2005) . Mdm2 is also reported to be extensively modified through a number of posttranslational modifications including ubiquitination, sumoylation and phosphorylation (Meek and Knippschild, 2003) . Although DNA damage is known to activate ATM kinase-induced phosphorylation of p53, it also targets Mdm2 at ser395 for phosphorylation in vitro (Maya et al., 2001) . Furthermore, two multisite phosphorylation clusters were identified in vivo at the N-terminus of Mdm2, the region comprising the p53-binding domain and nuclear localization signal (Hay and Meek, 2000) . Hypophosphorylation of putative sites within the acidic domain of Mdm2 reduced or ablated the ability of Mdm2 to degrade p53 (Blattner et al., 2002) . Together, the evidence suggests that, like phosphorylation of p53, Mdm2 phosphorylation inhibits Mdm2-directed turnover of p53.
The latest players in Mdm2 regulation are a subset of ribosomal proteins (RPs) with well-established extraribosomal function (Warner and McIntosh, 2009 ). The earliest evidence of RP interactions with Mdm2 occurred with the report of RPL5 binding to Mdm2 in a 5S ribosomal RNA (rRNA)-RPL5-Mdm2-p53 ribonucleoprotein complex, but at the time, the meaning of such an interaction was unclear (Marechal et al., 1994) .
Nearly a decade later, in screens seeking out novel Mdm2 modulating proteins, the large subunit RPs RPL5, RPL11 and RPL23 were all reported to bind to Mdm2, block the E3 ubiquitin ligase function of Mdm2, and promote p53 accumulation (Lohrum et al., 2003; Zhang et al., 2003; Bhat et al., 2004; . Following these initial reports, additional evidence subsequently was produced to support the roles of RPS7 (Chen et al., 2007; Zhu et al., 2009 ), RPL26 (Ofir-Rosenfeld et al., 2008 and RPS3 (Yadavilli et al., 2009) as Mdm2-binding partners. These studies served as the initial framework for establishing an RP-Mdm2-p53 stress response pathway.
In general, the current paradigm for ribosome biogenesis, largely derived from studies in bacteria and yeast systems, is the coordinated assembly of equimolar concentrations of RPs and rRNA to generate mature 80S polysomes that ensure adequate protein synthesis and maintain cellular homeostasis. In humans, this process requires the activity of RNA polymerase I (PolI) to generate the 47S precursor rRNA from clusters of ribosomal DNA (rDNA) tandem repeat genes. The precursor is further processed to 18S, 5.8S and 28S rRNAs. The fourth rRNA, 5S, is transcribed separately by RNA polymerase III (PolIII) in the nucleus, exported to the cytoplasm and finally imported to the nucleolus for incorporation into the large subunit (Szymanski et al., 2003) . The pool of 79 RPs are actively transcribed by RNA polymerase II, exported to the cytosol for translation and imported to the nucleolus for assembly (Lempiainen and Shore, 2009 ). In addition, there are a suite of auxiliary factors that assist in the processing of rRNA, assembly of the small and large subunits and finally export and maturation of the functional ribosome (Kressler et al., 1999; Venema and Tollervey, 1999) (Figure 1 ). Considering that this process is predicted to use 460% of resources in the cell (Warner, 1999) , it stands to reason that the coordinated activities of ribosome synthesis would be subject to extensive quality control surveillance.
The site for ribosome synthesis occurs in the nonmembrane bound structure of the nucleolus. Nucleolar organization regions form around rDNA gene clusters and are composed of a fibrillar center in which rDNA is transcribed, a dense fibrillar component in which rRNA undergoes extensive modification and cleavage processing, and a granular component in which the bulk of the RPs reside and assist in ribosomal subunit assembly. Approximately 30% of the nucleolar proteome consists of proteins involved in ribosome biogenesis, marking the nucleolus as the central location for ribosome assembly (Boisvert et al., 2007) .
Many of the reports analyzing RP-Mdm2 binding have alluded to 'nucleolar stress' as the event responsible for inducing the RP-Mdm2-p53 stress response. In this context, 'nucleolar stress' specifically refers to perturbations of ribosome biogenesis and the subsequent breakdown of nucleolar structure, resulting in activation of p53. In part, these observations have led to the hypothesis of the nucleolus as a central stress response regulator for p53 activation (Rubbi and Milner, 2003) . One technique that has been used to induce nucleolar stress is inhibition of precursor rRNA synthesis using low doses of actinomycin D (Bhat et al., 2004; , 5-flourouracil (Sun et al., 2007) and mycophenolic acid (Sun et al., 2008) . However, with regards to an RP-Mdm2-p53 pathway, it is imperative to identify the natural biological mechanisms of nucleolar stress, particularly as they pertain to ribosome biogenesis. In turn, identifying specific stressors of ribosome assembly that induce the RP-Mdm2-p53 pathway should provide greater mechanistic insight into the operational nature and biological function of the pathway, and more importantly, any contributions to human disease. For instance, why are there so many RPs that bind to and negatively regulate Mdm2? Do they have overlapping or redundant functions? Is the function of p53 in this context to suspend cell cycle progression until ribosome biogenesis is restored, or to remove individual cells from a population that are incapable of maintaining appropriate levels of protein synthesis? How can inactivation or modification of the RP-Mdm2-p53 pathway contribute to cancer? These questions are just the tip of the iceberg and will serve to move the field forward. This review will address how perturbations to three major components of ribosome biogenesis: rRNA, RPs and ribosome processing factors, trigger disruption of nucleolar integrity, thereby causing biological 'nucleolar stress' that may potentially activate the RP-Mdm2-p53 pathway.
Disruption of rRNA synthesis activates p53
The ongoing synthesis of new rRNA is an integral process of ribosome biogenesis. The transcription of 47S precursor and 5S rRNA, by PolI and PolIII respectively, is a process that needs to be continually monitored to Figure 1 A model for human ribosome biogenesis. Ribosome biogenesis requires coordinated expression of precursor 47S rRNA by RNA PolI, RPs and auxiliary factors by RNA PolII, and 5S RNA by RNA PolIII. Processing and assembly of the ribosomal subunits occurs in the nucleolus, followed by export of the subunits and assembly into mature ribosomes in the cytoplasm.
Ribosome biogenesis surveillance
C Deisenroth and Y Zhang ensure appropriate balance between rRNA availability, progression through modification and processing, and assembly into new ribosomes (Lempiainen and Shore, 2009 ). Inhibition of de novo precursor rRNA synthesis is one established mechanism for inducing ribosome biogenesis stress that is sufficient to activate the RPMdm2-p53 response. Manipulating rRNA production experimentally has typically involved treating with drugs that inhibit the activity of PolI or deplete the available pool of nucleotides for new rRNA synthesis. Actinomycin D is an antineoplastic antibiotic compound that has been used to inhibit cell proliferation. At low concentrations (o10 nM), the drug has been used to specifically disrupt ribosome biogenesis by inhibiting the production and availability of rRNA. With a high affinity for deoxyguanine nucleotides, actinomycin D preferentially intercalates into the GC rich regions of rDNA to inhibit PolI-mediated transcription of nascent 47S rRNA (Perry, 1963; Sobell et al., 1971) . Nearly all of the studies assessing the RP-Mdm2-p53 axis have used low-dose actinomycin D treatment as a means of inhibiting PolI activity, inducing nucleolar stress, and activating p53. Another commonly used chemotherapeutic compound 5-flourouracil is converted, in part, to 5-fluorouridine triphosphate, a uracil analog antimetabolite that functions by misincorporation into nascent RNA to block complete RNA synthesis (Longley et al., 2003) . Indeed, reduced dosages of 5-flourouracil (o10 mg/ml) were found to selectively enhance the association of RPL5, RPL11 and RPL23 with Mdm2 and activate p53, whereas knockdown of any of the three attenuated the p53 response (Sun et al., 2007) . Mycophenolic acid is another widely used chemotherapeutic agent that selectively inhibits inosine monophosphate dehydrogenase, an enzyme that synthesizes guanine nucleotides, to deplete the guanine nucleotide pool and disrupt pre-rRNA synthesis (Huang et al., 2008) . Mycophenolic acid-mediated disruption of ribosome production triggers nucleolar stress, subsequently facilitating the stabilization of p53 through RPL5 and RPL11-directed inhibition of Mdm2 (Sun et al., 2008) .
The significance of p53 activation through chemical inhibition of PolI activity has been further substantiated by identification of genetic perturbations that also disrupt rDNA transcription. For instance, the ablation of transcription factor TIF-IA in mouse embryonic fibroblasts, a factor essential for PolI-directed activity, leads to attenuation of rRNA transcription, loss of nucleolar integrity, elevation of p53 and activation of apoptosis (Yuan et al., 2005) . TIF-IA loss in the nervous system of mice also leads to deregulation of rRNA synthesis and elevation of p53 in neural progenitor and hippocampal neurons (Parlato et al., 2008) . Repression of the tumor-suppressor PTEN, a lipid phosphatase that blocks phosphatidylinositol 3 kinase signaling, is common in cancer and is known to enhance cell growth, proliferation and survival. Activation of PTEN has been shown to block recruitment of SL1 complexes to the promoter of rDNA genes, effectively reducing PolI transcription of precursor rRNA (Zhang et al., 2005) , suggesting that PTEN may in part exert tumor-suppressor function by contributing to nucleolar stress and activating p53. BAP28, a homolog of yeast Utp10, is involved in rDNA transcription and processing as a component of the U3 small nucleolar RNA-containing RNP complex. Mutation in the human homolog of BAP28 in the central nervous system of zebrafish alters rRNA synthesis and processing, resulting in p53-dependent apoptosis. The morphological defects are rescued by concomitant deletion of p53 (Azuma et al., 2006) , stressing the importance of p53 surveillance over ribosome biogenesis during central nervous system development in zebrafish. Finally, expression of the tumor-suppressor ARF blocks phosphorylation of upstream binding factor, a factor essential for initiation of the PolI transcription complex, to effectively inhibit rRNA transcription (Ayrault et al., 2006) . ARF is already a well-established Mdm2-binding partner, but inhibition of rRNA processing may provide an indirect route, by activating RP-Mdm2, to promote p53 stability.
Disruption of rRNA processing activates p53
A number of genetic models analyzing the importance of rRNA processing factors have highlighted the importance of rRNA fidelity for preservation of nucleolar integrity. Bop1 is a nucleolar protein involved in rRNA processing. Expression of a dominant-negative form of Bop1 in mouse cells blocks 28S and 5.8S rRNA formation, leading to impaired ribosome large subunit assembly and p53-dependent inhibition of cell cycle progression (Pestov et al., 2001) . Further analysis of Bop1 function revealed requirements for cleavage of the internal transcribed spacers ITS1 and ITS2, as well as the 3 0 external spacer, of precursor rRNA (Strezoska et al., 2002) . Together, the studies on Bop1 show how a nucleolar RNA processing factor involved in discrete steps in rRNA processing can transduce stress signals to p53 through a mediator that has yet to be determined. WDR12, a WD40 repeat protein reported to bind to a Pes1-Bop1 complex, is also essential for rRNA processing, and much like Bop1, alteration of WRD12 function can trigger a reversible p53-induced arrest of the cell cycle (Holzel et al., 2005) . As Bop1 and WDR12 are part of a complex, it seems reasonable to speculate that disruption of Pes1-Bop1-WDR12 functional activity may render a similar stress response. Although the activation of p53 through disablement of Pes1-Bop1-WDR12 rRNA processing is independent of ARFdirected inhibition of Mdm2, ARF has been shown to directly retard processing of precursor rRNA and delay the cell cycle (Sugimoto et al., 2003) . In addition to directly blocking rRNA synthesis and maturation, ARF can also bind to and degrade nucleophosmin/B23, a multifunctional nucleolar protein involved in precursor rRNA processing (Itahana et al., 2003; Bertwistle et al., 2004) . ARF may work on multiple levels to trigger nucleolar stress and work in conjunction with the RPMdm2-p53 pathway to activate p53 to retard or block cell cycle progression.
Additional work in mouse models highlights the effect of p53 surveillance on rRNA processing. Mutational inactivation of RNA-binding motif protein 19 (Rbm19) in mice, a protein contributing to rRNA processing, results in elevated p53 activity in the developing embryo, subsequently blocking development beyond the morula stage because of increased apoptosis . Moreover, deficiency of Wrd36, a protein essential for processing of 18S rRNA in zebrafish, was found to activate a p53-dependent response (Skarie and Link, 2008) . Collectively, these data support the notion that inappropriate accumulation of immature rRNA is sufficient to signal a stress response resulting in inhibition of cell cycle progression. Future experiments should aim to understand the precise nature of the p53-dependent stress response; focusing on the RPs reported to inhibit Mdm2 and characterize the significance of each under the specific conditions of rRNA processing perturbation.
RP imbalances activate p53
Decreased levels of certain RPs, resulting in an imbalance in the RP pool, have been extensively reported to induce p53 accumulation and transactivation of downstream genetic programs. Rps9 is a component of the small 40S subunit of the ribosome and knockdown in human cell lines has been shown to negatively affect cell proliferation by inducing p53-dependent cell cycle arrest (Lindstrom and Zhang, 2008) . The same is true for HIP/Rpl29, a component of the large 60S subunit, in which depletion of the protein was shown to induce accumulation of p53 and transactivation of p21 during cellular differentiation of colon cancer cells (Liu et al., 2006) . Given the presumed importance of specific RPs to inhibit Mdm2, it would seem logical that depletion of these Mdm2-binding partners would mitigate a p53-dependent response. This seems to be the case for Rpl11 (Bhat et al., 2004) , Rpl5 , Rps7 (Zhu et al., 2009) and Rps3 (Yadavilli et al., 2009) where, in the absence of stress, small interfering RNA knockdown had no effect on p53 stability. However, this was not the case for Rpl23, which was not only found to bind to and regulate the Mdm2-p53 interaction, but was also found to cause p53-dependent cell cycle arrest when depleted in cell culture models . The apparent discrepancies in the effect of RP depletion on p53 may suggest the existence of specific stress response points that depend on specific RPs to monitor the sequential assembly of new ribosomes.
Zebrafish models have provided more insight into the nature of RP deficiencies and regulation of p53. A largescale insertional mutagenesis screen identified 11 fish lines containing heterozygous mutations in RPs that showed elevated rates of malignant peripheral nerve sheath tumors, suggesting that some RPs may act as haploinsufficient tumor suppressors (Amsterdam et al., 2004) . Follow-up anlayses of 28 heterozygous RP mutant lines revealed that only a fraction of the lines were predisposed to malignant peripheral nerve sheath tumors, but those with the tumor development phenotype also showed a growth impairment defect (Lai et al., 2009) . Interestingly, development of malignant peripheral nerve sheath tumors was shown to be, in part, dependent on loss of p53 (Berghmans et al., 2005) . Loss of p53 synthesis was shown in zebrafish carrying select mutations in RPs that led to malignant peripheral nerve sheath tumors (MacInnes et al., 2008) , explaining, in part, why some haploinsufficient RP lines had decreased, in contrast to the expected increase, p53 protein levels and therefore enhanced rates of tumor development. Although some RP imbalances predispose zebrafish to tumor development, other imbalances have, in fact, been reported to induce a p53-dependent phenotype. Deficiency in Rps19, a gene commonly mutated in Diamond-Blackfan anemia, as well as Rps8, Rps11 and Rps18, resulted in hematopoietic and developmental abnormalities that could be rescued by concomitant loss of p53 (Danilova et al., 2008) . In addition, loss of Rpl11 also triggered developmental abnormalities and embryonic lethality because of p53-mediated apoptosis in morphant brains (Chakraborty et al., 2009) . Collectively, RP imbalances in zebrafish tend to modulate p53 levels up or down, depending on the specific mutation in question, and the overall capacity for proper ribosome functioning and protein synthesis. This may reflect a hierarchy among RPs in terms of their essential nature for ribosome biogenesis and mature ribosome function, as well as their ability to regulate p53. More studies are necessary to assess the role, if any, of an RP-Mdm2-p53 pathway in zebrafish.
Work in mouse models has begun to shed light on RP imbalances and induction of the RP-Mdm2-p53 regulatory pathway. In addition to being a structural component of a functional ribosome, Rps6 is also the well-established downstream effector of mTOR and S6 kinase signaling. T-cell-specific homozygous deletion of Rps6 resulted in complete impairment of T-cell development, whereas haploinsufficiency negatively altered T-cell accumulation in the spleen and lymph nodes in a process dependent on p53 (Sulic et al., 2005) . Moreover, deletion of a single Rps6 allele in growing oocytes was sufficient to support embryonic development until day E5.5, when p53 was subsequently activated to induce apoptosis, resulting in perigastrulation lethality (Panic et al., 2006) . However, although ablation of Rps6 in mouse liver was shown to activate p53 in an Rpl11-dependent manner, it did so in the absence of nucleolar disruption (Fumagalli et al., 2009) , suggesting that inherent nucleolar breakdown may not be a necessary requirement for transmitting ribosome biogenesis stress signals to p53. The ablation of Rpl22, a RP that may be essential for new ribosome synthesis, but dispensable for translation, was found to selectively block ab T-cell, but not gd T-cell, lineage progression by inducing a p53-dependent arrest (Anderson et al., 2007) . The selective block of development in one T-cell lineage, but not the other, provides evidence that p53-mediated surveillance of ribosome assembly may be more heavily weighted toward some cell types or possibly be stage specific.
Mutations in the small subunit Rps19 and Rps20 are reported to reduce overall body size and activate p53-dependent expression of Kit ligand, resulting in excessive pigmentation and a dark skin phenotype (aka epidermal malanocytosis) (McGowan et al., 2008) . Given the ubiquitous requirement of ribosome biogenesis in all cell types, it is surprising to find such a specific phenotype associated with disruption of ribosome synthesis and p53 induction, but this is not the only example of unusual defects observed in RP-deficient mice. The Belly Spot and Tail mouse is caused by a partial deletion in Rpl24 leading to congenital malformations of the eye and skeleton, in addition to the skin hyperpigmentation observed in other RP-deficient models (Tang et al., 1999; Oliver et al., 2004) . These defects are caused, in part, by elevated p53 levels, which contribute to the overall survival of the mice (Barkic et al., 2009) . The selective impairment of specific RPs in mouse models is sufficient to suggest the existence of an in vivo RP-Mdm2-p53 pathway, but further studies investigating the dependence of RP imbalances on this pathway and the specific defects associated with individual loss of RPs are warranted.
Nucleolar stress and human disease
The ubiquitous necessity of ribosome biogenesis implies that defects to the process may have a number of pleiotropic effects contributing to human disease. The term 'ribosomopathy' has been coined to describe clinical manifestations of ribosome biogenesis stress disorders (Luft, 2010) . One of the most frequent and well-characterized ribosome biogenesis diseases is Diamond-Blackfan anemia, a group of inherited bone marrow failure disorders (Ellis et al., 2008) . Although 25% of patients are reported to carry a mutation in Rps19, mutations in Rps7, Rps15, Rps17, Rps24, Rps27A, Rpl5, Rpl11, Rpl35A and Rpl36 have all been documented (Gazda et al., 2008; Maria Francesca et al., 2008) . In conjunction with chronic anemia and congenital abnormalities, Diamond-Blackfan anemia patients also harbor a predisposition to development of a number of cancers. Another example is dyskeratosis congenita, a rare X-linked condition characterized by accelerated aging and increased susceptibility to cancer (Ruggero et al., 2003) . Individuals with this disorder harbor a mutation in the psuedouridine synthase gene DKC1, resulting in rRNA processing deficiency and the clinical onset of the disease. Furthermore, another defect in rRNA processing is caused by mutations in the RNase enzyme RMRP. This mutation causes cartilage-hair hypoplasia, a disease leading to short stature, impaired immunity and predisposition to cancer (Ridanpa¨a¨et al., 2001) . Ribosomopathies may trigger the RP-Mdm2-p53 response and create pressure for selective loss or modification of p53, in part, explaining the susceptibility to cancer development.
Previous studies investigating the RP-Mdm2-p53 pathway have identified cancer-derived mutations that may bypass p53-mediated ribosome biogenesis surveillance. Mutation in the zinc-finger of Mdm2 disrupt the binding of Rpl5 and Rpl11, but not Rpl23, to bypass RP-mediated inhibition of Mdm2 (Lindstrom et al., 2007) . In general, most cancers ramp up the production of new ribosomes to support elevated levels of protein synthesis, so in this context, the RP-Mdm2-p53 pathway could have a more prominent role in tumor suppression. Future studies are necessary to assess the contribution of this pathway to human cancer.
Conclusions
The evidence shows how impaired rRNA synthesis, perturbations to rRNA modification and processing, or RP imbalance can all systematically disrupt ribosome biogenesis, thereby triggering stress to the nucleolus and inducing a p53-dependent response (Figure 2) . In some cases, like inhibition of rRNA synthesis, the mechanism of p53 stabilization has been shown to work through the RP-Mdm2-p53 pathway, but more analysis will be necessary to assess the precise mechanism and significance of this pathway to all of the examples that have been described. For instance, it has been suggested that inhibition of new rRNA synthesis would be expected to halt the progression of ribosome assembly, resulting in an excess of free RP. In turn, without adequate amount of rRNA to bind to free RP, RPs are available to interact with Mdm2 and stabilize p53 (Zhang and Lu, 2009) . A similar model could hold true for reduced availability or loss of function of individual RPs or processing factors. Reduction in levels of individual RPs might be expected to retard the progression of ribosome biogenesis. Accumulation of ribonucleoprotein Figure 2 Perturbations to ribosome biogenesis trigger a p53 response. Dysfunction at discrete phases of rRNA transcription, processing, and assembly during ribosome biogenesis are known to lead to p53-mediated responses. Select RPs are known to transduce nucleolar stress signals to p53, particularly in response to attenuation of rRNA transcription. The upstream mediators that signal p53-dependent stress responses arising from processing and assembly defects are less well characterized.
intermediates or unprocessed rRNA may be sufficient to stimulate the disorganization of the nucleolus, allowing a bevy of nucleolar factors to disperse in the nucleus. Among these factors are the RPs that bind to Mdm2 and trigger p53 stabilization. Finally, it may be possible to transduce stress signals to p53 in a more streamlined manner, without disorganization of the nucleolus, as has been previously shown (Fumagalli et al., 2009) . Perturbation to trigger points in the sequential processing and assembly of ribosomal subunits may rely on specific mediators to signal to p53. If individual RPs are responsible for transmitting signals from specific points of biogenesis remains to be determined.
So what is the biological purpose of p53 in monitoring synthesis of new ribosomes? Previous evidence has outlined a role for p53 in the inhibition of ribosome biogenesis, specifically RNA PolI and PolIII. Transcription of pre-rRNA is elevated in cells deficient for, or expressing mutant forms, of p53, indicating that p53 may suppress PolI-dependent transcription of rDNA (Budde and Grummt, 1999) . RNA PolI transcription is dependent on formation of an initiation complex containing the co-factors upstream binding factor and SL1. A direct protein-protein interaction between p53 and SL1 prevents the association of SL1 with upstream binding factor, thereby inhibiting the initiation of PolI transcription (Zhai and Comai, 2000) . In addition to PolI inhibition, p53 has been reported to be a general repressor of RNA PolIII (Chesnokov et al., 1996; Cairns and White, 1998) . By binding to TBP, a TATA-binding protein of the RNA PolIII cofactor TFIIIB complex, p53 blocks TFIIIB recruitment to PolIII-dependent promoters to inhibit transcription initiation (Crighton et al., 2003) . Given that PolI and III are subject to p53-dependent negative feedback, the purpose of p53 activation may be to temporarily block synthesis of rRNA to allow for self-correction between the balance of RPs, rRNA, and processing factors and accurately account for the rate-limiting component. In this way, transient activation of p53-dependent arrest can facilitate stalling cell cycle progression until there are adequate numbers of functional ribosomes to continue with cell expansion and division. This would be consistent with the necessity of sufficient cell growth for induction of cell division (Hartwell, 1971) . Along similar lines, any cell incapable of meeting a physiological standard for protein synthesis could be removed from the population by p53-mediated apoptosis or senescence. Future experimentation should address the precise mechanisms of ribosome biogenesis stress by clarifying the individual steps in the processing and assembly of new ribosomes. Deletion of the RPs that inhibit Mdm2 should allow for a systematic assessment of the individual requirements of each of these proteins in the RP-Mdm2-p53 stress response.
On a last note, given the well-characterized role for p53 in monitoring DNA integrity, we might naturally consider a role for p53 in the quality control surveillance of cellular RNA. rRNA represents the most actively transcribed, and therefore abundant, RNA in the cell, garnering upward of 50% of the transcriptional capacity of the cell (Sollner-Webb and Tower, 1986) . With such great abundance, there is high probability for some mutated or otherwise non-functional rRNA to be incorporated into a mature ribosome. This is certainly the case for yeast, in which the process of non-functional rRNA decay requires the ubiquitination and clearance of RPs that house defective rRNA in mature polysomes (Fujii et al., 2009) . The removal of RPs exposes the nonfunctional rRNA to RNAse enzymes that digest the RNA, rendering the ribosome inactive. In cell culture, ectopic overexpression of Mdm2 is known to be cytotoxic in some cases, but the mechanism is unclear. Mdm2-binding partners Rpl26 and Rps7 have been shown to be targets for ubiquitination by Mdm2 (OfirRosenfeld et al., 2008; Zhu et al., 2009) . Does Mdm2 have a part in degrading RPs from dysfunctional ribosomes? In this context, transient stabilization of p53 would induce Mdm2 levels to target non-functional ribosomes, ultimately exposing and facilitating the degradation of damaged rRNA. It remains to be determined whether or not p53 has as prominent a role in monitoring RNA damage as it does in maintaining genomic integrity.
